Charité hospital

Brief

Sickle cell disease and Thalassaemia are complex genetic blood disorders associated with high morbidity and mortality rates. However, over the last decade, new medications have become available and can extend both the duration and quality of paediatric patients’ lives. Despite this, medication adherence is low among this population, particularly during the transition from childhood to adulthood. Leading paediatric doctors Charité hospital, Berlin, approached Dr Curtis to help them develop a mobile health app to support Sickle Cell Disease and Thalassaemia patients’ medication adherence.

  • Applied Behaviour Change conducted a combination of consultancy and research to help the project team understand the barriers to medication adherence. We developed the research protocol and guided on focus groups with patients using a behavioural led approach. Analysis showed patients had a number of barriers towards medication adherence such as: forgetting to take their medication; the belief that medication had limited impact on their health; a dislike of relying on medication for their health; frustration with medication disrupting their social activities and; an over reliance on parents for medication reminders.

  • The project adopted a co-design approach to ensure patients were involved in all areas of the development process from understanding their challenges with medication adherence and preferences for app features, to usability evaluation of the prototype app.

  • Fundamental to this project was helping the project team who were not familiar with behavioural science to understand its value in mhealth design. Dr Curtis therefore lead on a workshop at Charité hospital for the project team (made up of paediatricians, app developers and user-experience designers) to help socialise the behaviour change model and approach.

Previous
Previous

Tictrac (now Dialogue)

Next
Next

Buckinghamshire Public Health Department